Canada Markets closed

ChemoCentryx, Inc. (CCXI)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
25.46+0.12 (+0.47%)
At close: 04:00PM EST
26.25 +0.79 (+3.10%)
After hours: 07:05PM EST
Currency in USD

Valuation Measures4

We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 1.80
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 370.29
52 Week Low 39.53
50-Day Moving Average 335.23
200-Day Moving Average 324.88

Share Statistics

Avg Vol (3 month) 31.47M
Avg Vol (10 day) 31.89M
Shares Outstanding 570.03M
Implied Shares Outstanding 6N/A
Float 857.71M
% Held by Insiders 117.64%
% Held by Institutions 164.64%
Shares Short (Dec. 14, 2021) 45.59M
Short Ratio (Dec. 14, 2021) 44.01
Short % of Float (Dec. 14, 2021) 411.79%
Short % of Shares Outstanding (Dec. 14, 2021) 47.98%
Shares Short (prior month Nov. 14, 2021) 46.04M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Sep. 29, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-348.58%

Management Effectiveness

Return on Assets (ttm)-15.11%
Return on Equity (ttm)-33.61%

Income Statement

Revenue (ttm)34.27M
Revenue Per Share (ttm)0.49
Quarterly Revenue Growth (yoy)248.90%
Gross Profit (ttm)-12.99M
EBITDA -116.93M
Net Income Avi to Common (ttm)-121.1M
Diluted EPS (ttm)-1.74
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)269.43M
Total Cash Per Share (mrq)3.85
Total Debt (mrq)72.95M
Total Debt/Equity (mrq)23.09
Current Ratio (mrq)4.89
Book Value Per Share (mrq)4.52

Cash Flow Statement

Operating Cash Flow (ttm)-83.96M
Levered Free Cash Flow (ttm)-91.6M